Innovent to Present New Clinical Data of Next-gen IO and ADC Pipeline at the 2026 ESMO Annual Meeting (PRNewswire) - Sep 23, 2026 - "Innovent Biologics, Inc...announces that clinical data for... IBI3001(EGFR/B7H3 ADC), IBI354(HER2 ADC) and TYVYT (sintilimab injection) will be presented at the 2026 European Society For Medical Oncology (ESMO) Annual Meeting from Oct 23 to Oct 27, 2026, in Madrid, Spain."
Clinical data • Breast Cancer • HER2 Positive Breast Cancer • Non Small Cell Lung Cancer
|